Last Updated: August 18, 2026

Amneal Pharms Co Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARMS CO

AMNEAL PHARMS CO has forty approved drugs.

Summary for Amneal Pharms Co

US Patents:	0
Tradenames:	39
Ingredients:	39
NDAs:	40

Drugs and US Patents for Amneal Pharms Co

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms Co	LURASIDONE HYDROCHLORIDE	lurasidone hydrochloride	TABLET;ORAL	208002-004	Jan 3, 2019		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Amneal Pharms Co	PARICALCITOL	paricalcitol	SOLUTION;INTRAVENOUS	206699-001	Mar 9, 2017	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Amneal Pharms Co	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	208105-002	Mar 17, 2016	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Amneal Pharms Co	TADALAFIL	tadalafil	TABLET;ORAL	209744-004	Mar 26, 2019	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Amneal Pharms Co	LEVOMILNACIPRAN HYDROCHLORIDE	levomilnacipran hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	210790-002	Feb 4, 2019		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Amneal Pharms Co	NADOLOL	nadolol	TABLET;ORAL	208832-003	Jun 2, 2017	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Amneal Pharms Co	CHLORPROMAZINE HYDROCHLORIDE	chlorpromazine hydrochloride	TABLET;ORAL	209755-001	Sep 10, 2018	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for AMNEAL PHARMS CO drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.